Bob Coates, Executive Chairman at Memgen, Inc.

Bob Coates

Executive Chairman at Memgen, Inc. | Houston, Texas, United States

Profile last verified October 2026
Biotechnology Verified Profile Houston, Texas, United States University of Chicago Graduate School of Business
Verified

Work Email

***@memgenbio.com

Last verified November 2026

Phone Number

903*****

United States • Mobile

Free account · No credit card · 5 profiles/month

Bob Coates Socials
Bob Coates Work Experience

Executive Chairman at Memgen, Inc. in August 2020 - Present

Chief Executive Officer at Memgen in January 2010 - January 2020

Bob Coates Education

University of Chicago Graduate School of Business

Bob Coates Skills
Biotechnology Start-ups Intellectual Property Strategy Hospitals Mergers & Acquisitions Healthcare EHR Venture Capital Entrepreneurship
See more See less
Executive Management
About Bob Coates’s Current Company
Memgen, Inc.

Memgen is a clinical-stage biotech company developing viral immunotherapies to harness the power of the immune system to potentially cure cancer and to protect people from infectious diseases. The Company’s pipeline products all utilize its proprietary CD40L transgene, MEM40, which has already demonstrated the ability to elicit powerful, antigen-specific immune responses. The Company’s lead cancer immunotherapy, MEM-288, was developed in collaboration with Moffitt Cancer Center. It is an oncolytic virus engineered to selectively target cancer cells and to supercharge the immune system through expression of two unique and powerful immune modulators: MEM40 and the powerful cytokine interferon beta. MEM-288 generates a strong systemic anti-tumor immune response following intra-tumoral vaccination in multiple tumors. Memgen is close to completing the monotherapy part of a clinical trial in advanced/metastatic NSCLC. Memgen's vaccine adjuvant, MemVax, is designed to be used in combination with other vaccines to generate a strong, durable immune response. MemVax is a highly specific immune stimulant that can work with antigens across a range of delivery approaches. Memgen has over 100,000 doses of MemVax ready to go into clinical trials, and an active file with the US FDA. Memgen plans to soon begin clinical trials of MemVax in collaboration with other companies developing complementary vaccines.

Discover more about Memgen, Inc.
Bob Coates’s Colleagues
TH

Travis Held

Tampa, Florida, United States

Accounting Manager at Memgen, Inc.

Accounting Manager at Memgen, Inc.
(August 2022 – Present)

OK

Odessa Kertzious

Georgetown, Demerara-Mahaica, Guyana

Student at Memgen, Inc.

Virtual Assistant and QuickBooks Assistant Bookkeeper at Megems Graphics LLC
(Mar 2021 – Present)

Search similar profiles
Frequently asked questions about Bob Coates

What is Bob Coates email address?

Email Bob Coates at [email protected]. This email is the most updated Bob Coates's email found in 2026.

How to contact Bob Coates?

To contact Bob Coates send an email to [email protected].

What company does Bob Coates work for?

Bob Coates works for Memgen, Inc..

What is Bob Coates's role at Memgen, Inc.?

Bob Coates is Executive Chairman

What industry does Bob Coates work in?

Bob Coates works in the Biotechnology industry.

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free